Park Medi World gets nod to acquire ‘V3 Healthcare’

Park Medi World Ltd. | Hospital & Healthcare Services | Healthcare | BSE: 544645 | NSE: PARKHOSPS

25 May 2026 Evaluate

Park Medi World has secured approval to acquire V3 Healthcare which operates a multi-super speciality Hospital in the name of ‘The Medicity Hospital’ for a consideration of around Rs 177 crore. The Board of Directors of the company at its meeting held on May 25, 2026 has approved the same. This acquisition marks Park Group’s entry into Uttarakhand, expanding its presence into a sixth state. It underscores the Group's continued commitment to disciplined and value-accretive inorganic growth.

The Medicity Hospital, Rudrapur, is a well-established multi-super speciality healthcare institution with a total capacity of 330 beds. As the largest hospital in the Kumaon region, the facility spanning over around 7,000 square meters of land with around 1.64 lakh square feet of covered area. Notably, the hospital is among the select NABH-accredited institutions in the region, reflecting commitment to the highest standards of clinical governance, patient safety, and operational quality. The hospital is equipped with advanced multi-disciplinary capabilities and modern medical infrastructure, staffed by a distinguished clinical team comprising specialists drawn from premier institutions of national repute. The facility operates with a strong patient-centric ethos, underpinned by a commitment to delivering superior clinical outcomes and enhancing the quality of care across the communities it serves.

This acquisition is consistent with the company's growth strategy, which seeks to maximise operational synergies and achieve economies of scale through strategic deployment of assets in high-potential, underserved markets. The addition of ‘The Medicity Hospital’ meaningfully strengthens Park Group's presence across key geographical areas in North India, advancing its long-term objective of building a dominant and integrated healthcare network in the region. The acquired facility will further strengthen the consolidated financial performance of Park Group, with value creation supported by a focused post-acquisition integration programme.

Park Medi World, operating under the brand 'Park Hospital', is the second largest private hospital chain in North India. The company is the Holding Company of Park Group of Hospitals.

Park Medi World Share Price

285.90 -1.50 (-0.52%)

04-Jun-2026 16:59 View Price Chart

Peers

Company Name	CMP
Apollo Hospital Ent.	8249.30
Max Healthcare Inst	966.25
Narayana Hrudayalay	1948.90
Aster DM Healthcare	738.65
Global Health	1229.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.